
Elli Peselev
Examiner (ID: 2405)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1203, 1623, 2899, 1802, 1211, 1621, 1803 |
| Total Applications | 2819 |
| Issued Applications | 1827 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7687558
[patent_doc_number] => 20090176733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'Novel Medicaments for Anti-Herpes Virus Treatments'
[patent_app_type] => utility
[patent_app_number] => 12/299365
[patent_app_country] => US
[patent_app_date] => 2007-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11892
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176733.pdf
[firstpage_image] =>[orig_patent_app_number] => 12299365
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/299365 | Medicaments for anti-herpes virus treatments | May 2, 2007 | Issued |
Array
(
[id] => 5586099
[patent_doc_number] => 20090105301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => '9A-SUBSTITUTED AZALIDES FOR THE TREATMENT OF MALARIA'
[patent_app_type] => utility
[patent_app_number] => 12/299042
[patent_app_country] => US
[patent_app_date] => 2007-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29424
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105301.pdf
[firstpage_image] =>[orig_patent_app_number] => 12299042
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/299042 | 9A-SUBSTITUTED AZALIDES FOR THE TREATMENT OF MALARIA | Apr 30, 2007 | Abandoned |
Array
(
[id] => 5016613
[patent_doc_number] => 20070259822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => '8A,11-BICYCLIC 8A-AZALIDE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 11/742794
[patent_app_country] => US
[patent_app_date] => 2007-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17763
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259822.pdf
[firstpage_image] =>[orig_patent_app_number] => 11742794
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/742794 | 8A,11-BICYCLIC 8A-AZALIDE DERIVATIVES | Apr 30, 2007 | Abandoned |
Array
(
[id] => 5272477
[patent_doc_number] => 20090076253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'MACROLIDE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/299229
[patent_app_country] => US
[patent_app_date] => 2007-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75712
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20090076253.pdf
[firstpage_image] =>[orig_patent_app_number] => 12299229
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/299229 | Macrolide derivatives | Apr 30, 2007 | Issued |
Array
(
[id] => 8214655
[patent_doc_number] => 08193341
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-05
[patent_title] => 'Inulin of very high chain length'
[patent_app_type] => utility
[patent_app_number] => 12/298689
[patent_app_country] => US
[patent_app_date] => 2007-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 19410
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/193/08193341.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298689
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298689 | Inulin of very high chain length | Apr 26, 2007 | Issued |
Array
(
[id] => 5479748
[patent_doc_number] => 20090202705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'INULIN OF VERY HIGH CHAIN LENGTH'
[patent_app_type] => utility
[patent_app_number] => 12/298680
[patent_app_country] => US
[patent_app_date] => 2007-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19981
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202705.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298680
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298680 | Inulin of very high chain length | Apr 26, 2007 | Issued |
Array
(
[id] => 4922543
[patent_doc_number] => 20080070859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Compounds resistant to metabolic deactivation and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/789809
[patent_app_country] => US
[patent_app_date] => 2007-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9198
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070859.pdf
[firstpage_image] =>[orig_patent_app_number] => 11789809
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/789809 | Compounds resistant to metabolic deactivation and methods of use | Apr 24, 2007 | Abandoned |
Array
(
[id] => 4644438
[patent_doc_number] => 08022043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-20
[patent_title] => 'Ceramide derivatives as modulators of immunity and autoimmunity'
[patent_app_type] => utility
[patent_app_number] => 11/785988
[patent_app_country] => US
[patent_app_date] => 2007-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 19259
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/022/08022043.pdf
[firstpage_image] =>[orig_patent_app_number] => 11785988
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/785988 | Ceramide derivatives as modulators of immunity and autoimmunity | Apr 22, 2007 | Issued |
Array
(
[id] => 6444479
[patent_doc_number] => 20100144656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'FEED OR PHARMACEUTICAL COMPOSITION COMPRISING APRAMYCIN OR AN ADEQUATE SALT THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/596644
[patent_app_country] => US
[patent_app_date] => 2007-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2749
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144656.pdf
[firstpage_image] =>[orig_patent_app_number] => 12596644
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/596644 | Feed or pharmaceutical composition comprising apramycin or an adequate salt thereof | Apr 18, 2007 | Issued |
Array
(
[id] => 4526350
[patent_doc_number] => 07923013
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-12
[patent_title] => 'Glycolipids and analogues thereof as antigens for NKT cells'
[patent_app_type] => utility
[patent_app_number] => 11/735313
[patent_app_country] => US
[patent_app_date] => 2007-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 43
[patent_no_of_words] => 29915
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/923/07923013.pdf
[firstpage_image] =>[orig_patent_app_number] => 11735313
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/735313 | Glycolipids and analogues thereof as antigens for NKT cells | Apr 12, 2007 | Issued |
Array
(
[id] => 7724322
[patent_doc_number] => 08097592
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-17
[patent_title] => 'Cocrystal of C-glycoside derivative and L-proline'
[patent_app_type] => utility
[patent_app_number] => 12/296056
[patent_app_country] => US
[patent_app_date] => 2007-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 5148
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/097/08097592.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296056
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296056 | Cocrystal of C-glycoside derivative and L-proline | Apr 3, 2007 | Issued |
Array
(
[id] => 42798
[patent_doc_number] => 07781407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-24
[patent_title] => 'Calcium gluconolactate compositions and methods of making same'
[patent_app_type] => utility
[patent_app_number] => 11/728728
[patent_app_country] => US
[patent_app_date] => 2007-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5657
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/781/07781407.pdf
[firstpage_image] =>[orig_patent_app_number] => 11728728
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/728728 | Calcium gluconolactate compositions and methods of making same | Mar 25, 2007 | Issued |
Array
(
[id] => 5189044
[patent_doc_number] => 20070167353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'PRODRUG COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 11/690528
[patent_app_country] => US
[patent_app_date] => 2007-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14314
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167353.pdf
[firstpage_image] =>[orig_patent_app_number] => 11690528
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/690528 | PRODRUG COMPOSITION | Mar 22, 2007 | Abandoned |
Array
(
[id] => 6002887
[patent_doc_number] => 20110118202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'Molecules which Bind to the Dimerization Initiation Site (DIS) of HIV RNA, Their Synthesis and Their Applications as Drugs'
[patent_app_type] => utility
[patent_app_number] => 12/225356
[patent_app_country] => US
[patent_app_date] => 2007-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 15836
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20110118202.pdf
[firstpage_image] =>[orig_patent_app_number] => 12225356
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225356 | Molecules which Bind to the Dimerization Initiation Site (DIS) of HIV RNA, Their Synthesis and Their Applications as Drugs | Mar 22, 2007 | Abandoned |
Array
(
[id] => 8146705
[patent_doc_number] => 08163713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-24
[patent_title] => 'Trehalose compound and pharmaceutical comprising the compound'
[patent_app_type] => utility
[patent_app_number] => 12/294800
[patent_app_country] => US
[patent_app_date] => 2007-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27541
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/163/08163713.pdf
[firstpage_image] =>[orig_patent_app_number] => 12294800
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/294800 | Trehalose compound and pharmaceutical comprising the compound | Mar 21, 2007 | Issued |
Array
(
[id] => 4977911
[patent_doc_number] => 20070219144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'IMMUNOMODULATORY SACCHARIDE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 11/687400
[patent_app_country] => US
[patent_app_date] => 2007-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 22264
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219144.pdf
[firstpage_image] =>[orig_patent_app_number] => 11687400
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/687400 | IMMUNOMODULATORY SACCHARIDE COMPOUNDS | Mar 15, 2007 | Abandoned |
Array
(
[id] => 8257848
[patent_doc_number] => 08207328
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-26
[patent_title] => 'Lactosamine derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/225094
[patent_app_country] => US
[patent_app_date] => 2007-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11154
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12225094
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225094 | Lactosamine derivatives | Mar 12, 2007 | Issued |
Array
(
[id] => 5131678
[patent_doc_number] => 20070208075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 11/715806
[patent_app_country] => US
[patent_app_date] => 2007-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7562
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20070208075.pdf
[firstpage_image] =>[orig_patent_app_number] => 11715806
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/715806 | Pharmaceutical compositions | Mar 7, 2007 | Abandoned |
Array
(
[id] => 5331282
[patent_doc_number] => 20090111759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'Synergistic Combination of Glutamate-and Gaba-Gated Chloride Agonist Pesticide and at Least One Vitamin E, Niacin, or Derivatives Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/224716
[patent_app_country] => US
[patent_app_date] => 2007-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16814
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111759.pdf
[firstpage_image] =>[orig_patent_app_number] => 12224716
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/224716 | Synergistic Combination of Glutamate-and Gaba-Gated Chloride Agonist Pesticide and at Least One Vitamin E, Niacin, or Derivatives Thereof | Mar 7, 2007 | Abandoned |
Array
(
[id] => 4989336
[patent_doc_number] => 20070155677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Separation method'
[patent_app_type] => utility
[patent_app_number] => 11/713861
[patent_app_country] => US
[patent_app_date] => 2007-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11902
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20070155677.pdf
[firstpage_image] =>[orig_patent_app_number] => 11713861
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/713861 | Separation method | Mar 4, 2007 | Issued |